Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    Trends in cancer · 2025
    JDJustin David Kaner
    PMID: 39863449DOISenior author6 citations

Publications

21 publications

Clinical research

3 studies

Active

2 studies
  • PI
    Cytokine Profiles in Patients with Suspected Hemophagocytic Lymphohistiocytosis (HLH) at New York Presbyterian/Weill Cornell Medical Center: A Single Center Retrospective Cohort Study
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2026)
  • PI
    A Multipart, Open-label, Single-arm, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
    PHASE2; PHASE3 · Electra Therapeutics INC · OPEN TO ACCRUAL (as of 2026)
    Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
    NCT05416307
Completed & closed trials (1)
  • PI
    Does nutritional supplementation affect outcomes in acute leukemia?
    Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2025)

External relationships

Advisory/Scientific Board Member

Electra Therapeutics INC · Sobi INC

Other

Sobi INC